Boston Scientificvs.Medtronic
BSX vs MDT · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Medtronic is about 1.6× larger than Boston Scientific by market cap; Boston Scientific trades at the lower P/E (18.7 vs 22.4); year to date, Medtronic leads (−12.7% vs −53.0%).
Side by side
| BSX | MDT | |
|---|---|---|
| Market cap | $66.5B | $107B |
| Price | $44.77 | $83.87 |
| Today | −0.5% | +1.8% |
| Return YTD | −53.0% | −12.7% |
| Return 1Y | −56.9% | −6.2% |
| P/E | 18.7 | 22.4 |
| P/S | 3.2 | 3.0 |
| P/B | 2.6 | 2.2 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →MedtronicMDT
World's largest medical device company — cardiology, surgery, neurology and diabetes treatment.
Full MDT profile →More comparisons in Medtech & devices
See where BSX and MDT sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →